Induction Chemotherapy Followed by Concomitant Chemoradiation in Head and Neck Squamous Cell Carcinoma: A Single Institution Experience
暂无分享,去创建一个
G. Delouya | D. Donath | D. Soulières | P. Nguyen-Tan | P. Després | E. Filion | B. Fortin | N. El-Bared | L. Guertin | S. Clavel | D. Charpentier
[1] G. Calais,et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. , 2009, Journal of the National Cancer Institute.
[2] R. Tishler,et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] Yu-xiong Su,et al. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis. , 2008, Chinese medical journal.
[4] D. Adelstein. Redefining the role of induction chemotherapy in head and neck cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Bhide,et al. Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer , 2008, British Journal of Cancer.
[6] T. Gorlia,et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. , 2007, The New England journal of medicine.
[7] A. Markoe,et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. , 2007, The New England journal of medicine.
[8] J. Pignon,et al. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update. , 2007, International journal of radiation oncology, biology, physics.
[9] J. Grandis,et al. Head and neck cancer: recent advances and new standards of care. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Leblanc,et al. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[12] A. Eisbruch,et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Carles,et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Shah,et al. TNM Staging of Cancers of the Head and Neck: Striving for Uniformity Among Diversity , 2005, CA: a cancer journal for clinicians.
[15] R. Tishler,et al. Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach. , 2004, Seminars in oncology.
[16] K. Rufibach,et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] A. Paccagnella,et al. Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. , 2004, Journal of the National Cancer Institute.
[18] L. Wilson,et al. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Jacobs,et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.
[20] M. van Glabbeke,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[21] A. Garden,et al. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? , 2004, Cancer.
[22] R. Weber,et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.
[23] R. Tishler,et al. Docetaxel, cisplatin, and 5‐fluorouracil‐based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck , 2003, Cancer.
[24] J. Bourhis,et al. End points for new agents in induction chemotherapy for locally advanced head and neck cancers. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[25] J. Pignon,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .
[26] D. Shin,et al. Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] B. Coche-Déquéant,et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma , 2000, British Journal of Cancer.
[28] R. Weichselbaum,et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Bourhis,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.
[30] P. Harari. Why has induction chemotherapy for advanced head and neck cancer become a United States community standard of practice? , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] M Schemper,et al. A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.
[32] L. Collette,et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. , 1996, Journal of the National Cancer Institute.
[33] A. Paccagnella,et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. , 1994, Journal of the National Cancer Institute.
[34] W. Hong,et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. , 1991, The New England journal of medicine.
[35] J. Jacobs,et al. Superior clinical response and survival rates with initial bolus of cisplatin and 120 hour infusion of 5-fluorouracil before definitive therapy for locally advanced head and neck cancer. , 1984, American journal of surgery.
[36] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[37] A. Garden,et al. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] D. Brizel,et al. Induction chemotherapy: to use or not to use? That is the question. , 2009, Seminars in radiation oncology.
[39] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[40] M. Leblanc,et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] K. Ang,et al. Concomitant chemotherapy and radiation therapy certainly improves local control. , 2005, International journal of radiation oncology, biology, physics.
[42] G. Calais,et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] J. Ensley,et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.